Bank of America’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-373,629
| Closed | -$10.1M | – | 8564 |
|
|
2022
Q4 | $10.1M | Buy |
373,629
+221,690
| +146% | +$5.83M | ﹤0.01% | 2682 |
|
|
2022
Q3 | $2.73M | Buy |
151,939
+111,367
| +274% | +$1.78M | ﹤0.01% | 4006 |
|
|
2022
Q2 | $504K | Sell |
40,572
-147,276
| -78% | -$1.63M | ﹤0.01% | 5424 |
|
|
2022
Q1 | $2.5M | Buy |
187,848
+33,895
| +22% | +$455K | ﹤0.01% | 4373 |
|
|
2021
Q4 | $2.4M | Buy |
153,953
+143,725
| +1,405% | +$2.74M | ﹤0.01% | 4379 |
|
|
2021
Q3 | $230K | Buy |
10,228
+557
| +6% | +$12.2K | ﹤0.01% | 6210 |
|
|
2021
Q2 | $220K | Buy |
9,671
+2,911
| +43% | +$61.2K | ﹤0.01% | 6031 |
|
|
2021
Q1 | $139K | Buy |
6,760
+2,621
| +63% | +$59.7K | ﹤0.01% | 6253 |
|
|
2020
Q4 | $115K | Sell |
4,139
-157
| -4% | -$3.06K | ﹤0.01% | 5915 |
|
|
2020
Q3 | $60K | Sell |
4,296
-239
| -5% | -$4.45K | ﹤0.01% | 5947 |
|
|
2020
Q2 | $93K | Sell |
4,535
-1,674
| -27% | -$22.8K | ﹤0.01% | 5711 |
|
|
2020
Q1 | $47K | Sell |
6,209
-2,175
| -26% | -$24.4K | ﹤0.01% | 5896 |
|
|
2019
Q4 | $130K | Sell |
8,384
-113,997
| -93% | -$1.15M | ﹤0.01% | 5870 |
|
|
2019
Q3 | $636K | Buy |
122,381
+108,740
| +797% | +$807K | ﹤0.01% | 4903 |
|
|
2019
Q2 | $123K | Buy |
13,641
+9,736
| +249% | +$145K | ﹤0.01% | 5898 |
|
|
2019
Q1 | $93K | Buy |
3,905
+3,661
| +1,500% | +$74.9K | ﹤0.01% | 5923 |
|
|
2018
Q4 | $4K | Buy |
244
+147
| +152% | +$2.9K | ﹤0.01% | 6808 |
|
|
2018
Q3 | $2K | Sell |
97
-1,515
| -94% | -$34.3K | ﹤0.01% | 7060 |
|
|
2018
Q2 | $37K | Sell |
1,612
-1,640
| -50% | -$35.8K | ﹤0.01% | 6292 |
|
|
2018
Q1 | $70K | Buy |
3,252
+1,757
| +118% | +$26.7K | ﹤0.01% | 5907 |
|
|
2017
Q4 | $19K | Buy |
1,495
+17
| +1% | +$228 | ﹤0.01% | 6434 |
|
|
2017
Q3 | $23K | Sell |
1,478
-3,966
| -73% | -$48.2K | ﹤0.01% | 6229 |
|
|
2017
Q2 | $63K | Buy |
5,444
+3,562
| +189% | +$44.1K | ﹤0.01% | 5784 |
|
|
2017
Q1 | $22K | Buy |
1,882
+422
| +29% | +$4.84K | ﹤0.01% | 6285 |
|
|
2016
Q4 | $18K | Buy |
+1,460
| New | +$16.9K | ﹤0.01% | 6386 |
|
Other funds holding MYOV
Bank of America's MYOV Position: Q1 2023 in Review
Bank of America sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 373,629 shares — an estimated $10.1M sold.
Bank of America first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $10.1M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Bank of America reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Bank of America sold 373,629 Myovant Sciences Ltd. shares in Q1 2023, an estimated $10.1M.
- Bank of America first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
- Bank of America's Myovant Sciences Ltd. position peaked at $10.1M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.